CRISPR Technology Market size is expected to reach US$ 5.79 Bn. by year 2029 at a CAGR of 23.5% during the forecast period. The report study has analyzed revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report CRISPR is a gene editing technology, which offers the potential for substantial improvement over other gene editing technologies. An introduction of genome editing with engineered nucleases has taken genetic engineering to the next level. The CRISPR technology is rapidly gaining prominence as a genome editing tool.
CRISPR Technology Market, Dynamics:
The CRISPR technology market is expected to grow at a rapid rate during the forecast period because of the its high demand acorss the globe. It is expected to witness high growth as CRISPR technology is used in various process like DNA sequence, DNA repair, gene library development, cell line engineering, and genetic engineering. It is also used in treatment and other medical procedures like cancer, hepatitis B, gene therapy. Additionally, high investment in the field of research and development by various key players for the development of the CRISPR technology is boosting growth of the global CRISPR technology market. On the other hand, lack of knowledge about the technology and the high cost of implementation of the Cas9 technology are expected to limit the global CRISPR technology market growth. An introduction of new gene-editing technologies is transforming human therapeutics, agriculture, and industrial biotechnology across the globe. Advancements in clustered structure are regularly interspaced short palindromic repeats (CRISPR), which also have created a fertile environment for mass-scale manufacturing of cost-effective products. CRISPR technology has gained significant traction and established its dominance. The most of the gene-editing technologies are originating from the industry. The CRISPR has been pioneered by academic research institutions. The spinout of CRISPR biotechnology key players from academic institutions are demonstrating a shift in entrepreneurship strategies that were beforehand led by the industry. The academic institutions and their subsequent companies are contending to generate comprehensive intellectual property portfolios to increase the efficiency of commercialize CRISPR products.CRISPR Technology Market, Regional Analysis:
North America is the leading market in global CRISPR technology. The developed countries like U.S. and Canada have a strict regulation on manufacturing of medical devices and giving medical services, which improves the quality of devices and technology. The availibility of the quality of products, devices, technology and service offered by the healthcare industry are expected to boost the market growth. Expantion of the biotechnology industry and the speedy implementation of progressive technologies like CAS9 are also propelling the regional growth. Furthermore, Europe region is also responsible for the next principal market share in global CRISPR technology market because of the widespread CRISPR/CAS research in the biotechnology and pharmaceutical community and awareness for the technology. The CAS9 technology market in the Europe region is projected to reach US$ xx Mn by 2029 from US$ xx Mn in 2022.CRISPR Technology Market, Competitive Analysis:
Global CRISPR Technology Market growth is reliant on government support, market conditions and industry development across the globe. Some of the prominent key players opearating in the global CRISPR technology market are principally focusing on the development of new products. The global companies are dominating the market and regional and foreign players with small market shares are also expected to establish a strong presence in the market. Many key players are increasingly optimizing their strategies to deliver cost-efficient and high-quality products for a strongly competitive market setting. The objective of the report is to present a comprehensive analysis of the Global CRISPR Technology Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global CRISPR Technology Market dynamics, structure by analyzing the market segments and projects the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global CRISPR Technology Market make the report investor’s guide.CRISPR Technology Market Scope: Inquire before buying
Global CRISPR Technology Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.32 Bn. Forecast Period 2023 to 2029 CAGR: 23.5% Market Size in 2029: US $ 5.79 Bn. Segments Covered: by Offering Products Services by Application Biomedical Applications Agricultural Applications Industrial Applications Biological Research by End User Pharmaceutical and Biopharmaceutical Companies Biotechnology Companies Academic and Research Institutes Contract Research Organizations Global CRISPR Technology Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global CRISPR Technology Market, Key Players
1. Cellecta, Inc. 2. GeneCopoeia, Inc. 3. New England Biolabs 4. Origene Technologies, Inc. 5. Synthego Corporation 6. Toolgen, Inc. 7. Thermo Fisher Scientific 8. Merck KGaA 9. GenScript 10.Integrated DNA Technologies (IDT) 11.Horizon Discovery Group 12.Agilent Technologies 13.Applied StemCell 14.Editas Medicine 15.Transposagenbio Biopharmaceuticals 16.Intellia Therapeutics Inc. Frequently Asked Questions: 1. Which region has the largest share in Global CRISPR Technology Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global CRISPR Technology Market? Ans: The Global Market is growing at a CAGR of 23.5% during forecasting period 2023-2029. 3. What is scope of the Global market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – Cellecta, Inc., GeneCopoeia, Inc., New England Biolabs, Origene Technologies, Inc., Synthego Corporation, Toolgen, Inc., Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), and Horizon Discovery Group. 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
Global CRISPR Technology Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global CRISPR Technology Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global CRISPR Technology Market Analysis and Forecast 6.1. CRISPR Technology Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global CRISPR Technology Market Analysis and Forecast, By Offering 7.1. Introduction and Definition 7.2. Key Findings 7.3. CRISPR Technology Market Value Share Analysis, By Offering 7.4. CRISPR Technology Market Size (US$ Mn) Forecast, By Offering 7.5. CRISPR Technology Market Analysis, By Offering 7.6. CRISPR Technology Market Attractiveness Analysis, By Offering 8. Global CRISPR Technology Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. CRISPR Technology Market Value Share Analysis, By Application 8.4. CRISPR Technology Market Size (US$ Mn) Forecast, By Application 8.5. CRISPR Technology Market Analysis, By Application 8.6. CRISPR Technology Market Attractiveness Analysis, By Application 9. Global CRISPR Technology Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. CRISPR Technology Market Value Share Analysis, By End User 9.4. CRISPR Technology Market Size (US$ Mn) Forecast, By End User 9.5. CRISPR Technology Market Analysis, By End User 9.6. CRISPR Technology Market Attractiveness Analysis, By End User 10. Global CRISPR Technology Market Analysis, by Region 10.1. CRISPR Technology Market Value Share Analysis, by Region 10.2. CRISPR Technology Market Size (US$ Mn) Forecast, by Region 10.3. CRISPR Technology Market Attractiveness Analysis, by Region 11. North America CRISPR Technology Market Analysis 11.1. Key Findings 11.2. North America CRISPR Technology Market Overview 11.3. North America CRISPR Technology Market Value Share Analysis, By Offering 11.4. North America CRISPR Technology Market Forecast, By Offering 11.4.1. Products 11.4.2. Services 11.5. North America CRISPR Technology Market Value Share Analysis, By Application 11.6. North America CRISPR Technology Market Forecast, By Application 11.6.1. Biomedical Application 11.6.2. Agricultural Application 11.6.3. Industrial Application 11.6.4. Biological Research 11.7. North America CRISPR Technology Market Value Share Analysis, By End User 11.8. North America CRISPR Technology Market Forecast, By End User 11.8.1. Pharmaceutical and Biopharmaceutical Companies 11.8.2. Biotechnology Companies 11.8.3. Academic and Research Institutes 11.8.4. Contract Research Organizations 11.9. North America CRISPR Technology Market Value Share Analysis, by Country 11.10. North America CRISPR Technology Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America CRISPR Technology Market Analysis, by Country 11.12. U.S. CRISPR Technology Market Forecast, By Offering 11.12.1. Products 11.12.2. Services 11.13. U.S. CRISPR Technology Market Forecast, By Application 11.13.1. Biomedical Application 11.13.2. Agricultural Application 11.13.3. Industrial Application 11.13.4. Biological Research 11.14. U.S. CRISPR Technology Market Forecast, By End User 11.14.1. Pharmaceutical and Biopharmaceutical Companies 11.14.2. Biotechnology Companies 11.14.3. Academic and Research Institutes 11.14.4. Contract Research Organizations 11.15. Canada CRISPR Technology Market Forecast, By Offering 11.15.1. Products 11.15.2. Services 11.16. Canada CRISPR Technology Market Forecast, By Application 11.16.1. Biomedical Application 11.16.2. Agricultural Application 11.16.3. Industrial Application 11.16.4. Biological Research 11.17. Canada CRISPR Technology Market Forecast, By End User 11.17.1. Pharmaceutical and Biopharmaceutical Companies 11.17.2. Biotechnology Companies 11.17.3. Academic and Research Institutes 11.17.4. Contract Research Organizations 11.18. North America CRISPR Technology Market Attractiveness Analysis 11.18.1. By Offering 11.18.2. By Application 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe CRISPR Technology Market Analysis 12.1. Key Findings 12.2. Europe CRISPR Technology Market Overview 12.3. Europe CRISPR Technology Market Value Share Analysis, By Offering 12.4. Europe CRISPR Technology Market Forecast, By Offering 12.4.1. Products 12.4.2. Services 12.5. Europe CRISPR Technology Market Value Share Analysis, By Application 12.6. Europe CRISPR Technology Market Forecast, By Application 12.6.1. Biomedical Application 12.6.2. Agricultural Application 12.6.3. Industrial Application 12.6.4. Biological Research 12.7. Europe CRISPR Technology Market Value Share Analysis, By End User 12.8. Europe CRISPR Technology Market Forecast, By End User 12.8.1. Pharmaceutical and Biopharmaceutical Companies 12.8.2. Biotechnology Companies 12.8.3. Academic and Research Institutes 12.8.4. Contract Research Organizations 12.9. Europe CRISPR Technology Market Value Share Analysis, by Country 12.10. Europe CRISPR Technology Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe CRISPR Technology Market Analysis, by Country 12.12. Germany CRISPR Technology Market Forecast, By Offering 12.12.1. Products 12.12.2. Services 12.13. Germany CRISPR Technology Market Forecast, By Application 12.13.1. Biomedical Application 12.13.2. Agricultural Application 12.13.3. Industrial Application 12.13.4. Biological Research 12.14. Germany CRISPR Technology Market Forecast, By End User 12.14.1. Pharmaceutical and Biopharmaceutical Companies 12.14.2. Biotechnology Companies 12.14.3. Academic and Research Institutes 12.14.4. Contract Research Organizations 12.15. U.K. CRISPR Technology Market Forecast, By Offering 12.15.1. Products 12.15.2. Services 12.16. U.K. CRISPR Technology Market Forecast, By Application 12.16.1. Biomedical Application 12.16.2. Agricultural Application 12.16.3. Industrial Application 12.16.4. Biological Research 12.17. U.K. CRISPR Technology Market Forecast, By End User 12.17.1. Pharmaceutical and Biopharmaceutical Companies 12.17.2. Biotechnology Companies 12.17.3. Academic and Research Institutes 12.17.4. Contract Research Organizations 12.18. France CRISPR Technology Market Forecast, By Offering 12.18.1. Products 12.18.2. Services 12.19. France CRISPR Technology Market Forecast, By Application 12.19.1. Biomedical Application 12.19.2. Agricultural Application 12.19.3. Industrial Application 12.19.4. Biological Research 12.20. France CRISPR Technology Market Forecast, By End User 12.20.1. Pharmaceutical and Biopharmaceutical Companies 12.20.2. Biotechnology Companies 12.20.3. Academic and Research Institutes 12.20.4. Contract Research Organizations 12.21. Italy CRISPR Technology Market Forecast, By Offering 12.21.1. Products 12.21.2. Services 12.22. Italy CRISPR Technology Market Forecast, By Application 12.22.1. Biomedical Application 12.22.2. Agricultural Application 12.22.3. Industrial Application 12.22.4. Biological Research 12.23. Italy CRISPR Technology Market Forecast, By End User 12.23.1. Pharmaceutical and Biopharmaceutical Companies 12.23.2. Biotechnology Companies 12.23.3. Academic and Research Institutes 12.23.4. Contract Research Organizations 12.24. Spain CRISPR Technology Market Forecast, By Offering 12.24.1. Products 12.24.2. Services 12.25. Spain CRISPR Technology Market Forecast, By Application 12.25.1. Biomedical Application 12.25.2. Agricultural Application 12.25.3. Industrial Application 12.25.4. Biological Research 12.26. Spain CRISPR Technology Market Forecast, By End User 12.26.1. Pharmaceutical and Biopharmaceutical Companies 12.26.2. Biotechnology Companies 12.26.3. Academic and Research Institutes 12.26.4. Contract Research Organizations 12.27. Rest of Europe CRISPR Technology Market Forecast, By Offering 12.27.1. Products 12.27.2. Services 12.28. Rest of Europe CRISPR Technology Market Forecast, By Application 12.28.1. Biomedical Application 12.28.2. Agricultural Application 12.28.3. Industrial Application 12.28.4. Biological Research 12.29. Rest of Europe CRISPR Technology Market Forecast, By End User 12.29.1. Pharmaceutical and Biopharmaceutical Companies 12.29.2. Biotechnology Companies 12.29.3. Academic and Research Institutes 12.29.4. Contract Research Organizations 12.30. Europe CRISPR Technology Market Attractiveness Analysis 12.30.1. By Offering 12.30.2. By Application 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific CRISPR Technology Market Analysis 13.1. Key Findings 13.2. Asia Pacific CRISPR Technology Market Overview 13.3. Asia Pacific CRISPR Technology Market Value Share Analysis, By Offering 13.4. Asia Pacific CRISPR Technology Market Forecast, By Offering 13.4.1. Products 13.4.2. Services 13.5. Asia Pacific CRISPR Technology Market Value Share Analysis, By Application 13.6. Asia Pacific CRISPR Technology Market Forecast, By Application 13.6.1. Biomedical Application 13.6.2. Agricultural Application 13.6.3. Industrial Application 13.6.4. Biological Research 13.7. Asia Pacific CRISPR Technology Market Value Share Analysis, By End User 13.8. Asia Pacific CRISPR Technology Market Forecast, By End User 13.8.1. Pharmaceutical and Biopharmaceutical Companies 13.8.2. Biotechnology Companies 13.8.3. Academic and Research Institutes 13.8.4. Contract Research Organizations 13.9. Asia Pacific CRISPR Technology Market Value Share Analysis, by Country 13.10. Asia Pacific CRISPR Technology Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific CRISPR Technology Market Analysis, by Country 13.12. China CRISPR Technology Market Forecast, By Offering 13.12.1. Products 13.12.2. Services 13.13. China CRISPR Technology Market Forecast, By Application 13.13.1. Biomedical Application 13.13.2. Agricultural Application 13.13.3. Industrial Application 13.13.4. Biological Research 13.14. China CRISPR Technology Market Forecast, By End User 13.14.1. Pharmaceutical and Biopharmaceutical Companies 13.14.2. Biotechnology Companies 13.14.3. Academic and Research Institutes 13.14.4. Contract Research Organizations 13.15. India CRISPR Technology Market Forecast, By Offering 13.15.1. Products 13.15.2. Services 13.16. India CRISPR Technology Market Forecast, By Application 13.16.1. Biomedical Application 13.16.2. Agricultural Application 13.16.3. Industrial Application 13.16.4. Biological Research 13.17. India CRISPR Technology Market Forecast, By End User 13.17.1. Pharmaceutical and Biopharmaceutical Companies 13.17.2. Biotechnology Companies 13.17.3. Academic and Research Institutes 13.17.4. Contract Research Organizations 13.18. Japan CRISPR Technology Market Forecast, By Offering 13.18.1. Products 13.18.2. Services 13.19. Japan CRISPR Technology Market Forecast, By Application 13.19.1. Biomedical Application 13.19.2. Agricultural Application 13.19.3. Industrial Application 13.19.4. Biological Research 13.20. Japan CRISPR Technology Market Forecast, By End User 13.20.1. Pharmaceutical and Biopharmaceutical Companies 13.20.2. Biotechnology Companies 13.20.3. Academic and Research Institutes 13.20.4. Contract Research Organizations 13.21. ASEAN CRISPR Technology Market Forecast, By Offering 13.21.1. Products 13.21.2. Services 13.22. ASEAN CRISPR Technology Market Forecast, By Application 13.22.1. Biomedical Application 13.22.2. Agricultural Application 13.22.3. Industrial Application 13.22.4. Biological Research 13.23. ASEAN CRISPR Technology Market Forecast, By End User 13.23.1. Pharmaceutical and Biopharmaceutical Companies 13.23.2. Biotechnology Companies 13.23.3. Academic and Research Institutes 13.23.4. Contract Research Organizations 13.24. Rest of Asia Pacific CRISPR Technology Market Forecast, By Offering 13.24.1. Products 13.24.2. Services 13.25. Rest of Asia Pacific CRISPR Technology Market Forecast, By Application 13.25.1. Biomedical Application 13.25.2. Agricultural Application 13.25.3. Industrial Application 13.25.4. Biological Research 13.26. Rest of Asia Pacific CRISPR Technology Market Forecast, By End User 13.26.1. Pharmaceutical and Biopharmaceutical Companies 13.26.2. Biotechnology Companies 13.26.3. Academic and Research Institutes 13.26.4. Contract Research Organizations 13.27. Asia Pacific CRISPR Technology Market Attractiveness Analysis 13.27.1. By Offering 13.27.2. By Application 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa CRISPR Technology Market Analysis 14.1. Key Findings 14.2. Middle East & Africa CRISPR Technology Market Overview 14.3. Middle East & Africa CRISPR Technology Market Value Share Analysis, By Offering 14.4. Middle East & Africa CRISPR Technology Market Forecast, By Offering 14.4.1. Products 14.4.2. Services 14.5. Middle East & Africa CRISPR Technology Market Value Share Analysis, By Application 14.6. Middle East & Africa CRISPR Technology Market Forecast, By Application 14.6.1. Biomedical Application 14.6.2. Agricultural Application 14.6.3. Industrial Application 14.6.4. Biological Research 14.7. Middle East & Africa CRISPR Technology Market Value Share Analysis, By End User 14.8. Middle East & Africa CRISPR Technology Market Forecast, By End User 14.8.1. Pharmaceutical and Biopharmaceutical Companies 14.8.2. Biotechnology Companies 14.8.3. Academic and Research Institutes 14.8.4. Contract Research Organizations 14.9. Middle East & Africa CRISPR Technology Market Value Share Analysis, by Country 14.10. Middle East & Africa CRISPR Technology Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa CRISPR Technology Market Analysis, by Country 14.12. GCC CRISPR Technology Market Forecast, By Offering 14.12.1. Products 14.12.2. Services 14.13. GCC CRISPR Technology Market Forecast, By Application 14.13.1. Biomedical Application 14.13.2. Agricultural Application 14.13.3. Industrial Application 14.13.4. Biological Research 14.14. GCC CRISPR Technology Market Forecast, By End User 14.14.1. Pharmaceutical and Biopharmaceutical Companies 14.14.2. Biotechnology Companies 14.14.3. Academic and Research Institutes 14.14.4. Contract Research Organizations 14.15. South Africa CRISPR Technology Market Forecast, By Offering 14.15.1. Products 14.15.2. Services 14.16. South Africa CRISPR Technology Market Forecast, By Application 14.16.1. Biomedical Application 14.16.2. Agricultural Application 14.16.3. Industrial Application 14.16.4. Biological Research 14.17. South Africa CRISPR Technology Market Forecast, By End User 14.17.1. Pharmaceutical and Biopharmaceutical Companies 14.17.2. Biotechnology Companies 14.17.3. Academic and Research Institutes 14.17.4. Contract Research Organizations 14.18. Rest of Middle East & Africa CRISPR Technology Market Forecast, By Offering 14.18.1. Products 14.18.2. Services 14.19. Rest of Middle East & Africa CRISPR Technology Market Forecast, By Application 14.19.1. Biomedical Application 14.19.2. Agricultural Application 14.19.3. Industrial Application 14.19.4. Biological Research 14.20. Rest of Middle East & Africa CRISPR Technology Market Forecast, By End User 14.20.1. Pharmaceutical and Biopharmaceutical Companies 14.20.2. Biotechnology Companies 14.20.3. Academic and Research Institutes 14.20.4. Contract Research Organizations 14.21. Middle East & Africa CRISPR Technology Market Attractiveness Analysis 14.21.1. By Offering 14.21.2. By Application 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America CRISPR Technology Market Analysis 15.1. Key Findings 15.2. South America CRISPR Technology Market Overview 15.3. South America CRISPR Technology Market Value Share Analysis, By Offering 15.4. South America CRISPR Technology Market Forecast, By Offering 15.4.1. Products 15.4.2. Services 15.5. South America CRISPR Technology Market Value Share Analysis, By Application 15.6. South America CRISPR Technology Market Forecast, By Application 15.6.1. Biomedical Application 15.6.2. Agricultural Application 15.6.3. Industrial Application 15.6.4. Biological Research 15.7. South America CRISPR Technology Market Value Share Analysis, By End User 15.8. South America CRISPR Technology Market Forecast, By End User 15.8.1. Pharmaceutical and Biopharmaceutical Companies 15.8.2. Biotechnology Companies 15.8.3. Academic and Research Institutes 15.8.4. Contract Research Organizations 15.9. South America CRISPR Technology Market Value Share Analysis, by Country 15.10. South America CRISPR Technology Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America CRISPR Technology Market Analysis, by Country 15.12. Brazil CRISPR Technology Market Forecast, By Offering 15.12.1. Products 15.12.2. Services 15.13. Brazil CRISPR Technology Market Forecast, By Application 15.13.1. Biomedical Application 15.13.2. Agricultural Application 15.13.3. Industrial Application 15.13.4. Biological Research 15.14. Brazil CRISPR Technology Market Forecast, By End User 15.14.1. Pharmaceutical and Biopharmaceutical Companies 15.14.2. Biotechnology Companies 15.14.3. Academic and Research Institutes 15.14.4. Contract Research Organizations 15.15. Mexico CRISPR Technology Market Forecast, By Offering 15.15.1. Products 15.15.2. Services 15.16. Mexico CRISPR Technology Market Forecast, By Application 15.16.1. Biomedical Application 15.16.2. Agricultural Application 15.16.3. Industrial Application 15.16.4. Biological Research 15.17. Mexico CRISPR Technology Market Forecast, By End User 15.17.1. Pharmaceutical and Biopharmaceutical Companies 15.17.2. Biotechnology Companies 15.17.3. Academic and Research Institutes 15.17.4. Contract Research Organizations 15.18. Rest of South America CRISPR Technology Market Forecast, By Offering 15.18.1. Products 15.18.2. Services 15.19. Rest of South America CRISPR Technology Market Forecast, By Application 15.19.1. Biomedical Application 15.19.2. Agricultural Application 15.19.3. Industrial Application 15.19.4. Biological Research 15.20. Rest of South America CRISPR Technology Market Forecast, By End User 15.20.1. Pharmaceutical and Biopharmaceutical Companies 15.20.2. Biotechnology Companies 15.20.3. Academic and Research Institutes 15.20.4. Contract Research Organizations 15.21. South America CRISPR Technology Market Attractiveness Analysis 15.21.1. By Offering 15.21.2. By Application 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, End User s and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.4. M&A by Regions, Investment and End User s 16.2.5. M&A Key Players, Forward Integration and Backward 16.2.6. Integration 16.3. Company Profiles: Key Players 16.3.1. Cellecta, Inc. 16.3.1.1.Company Overview 16.3.1.2.Financial Overview 16.3.1.3.Product Portfolio 16.3.1.4.Business Strategy 16.3.1.5.Recent Developments 16.3.1.6.Development Footprint 16.3.2. GeneCopoeia, Inc. 16.3.3. New England Biolabs 16.3.4. Origene Technologies, Inc. 16.3.5. Synthego Corporation 16.3.6. Toolgen, Inc. 16.3.7. Thermo Fisher Scientific 16.3.8. Merck KGaA 16.3.9. GenScript 16.3.10. Integrated DNA Technologies (IDT) 16.3.11. Horizon Discovery Group 16.3.12. Agilent Technologies 16.3.13. Applied StemCell 16.3.14. Editas Medicine 16.3.15. Transposagenbio Biopharmaceuticals 16.3.16. Intellia Therapeutics Inc.